| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -4.7e-05 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 9.4e-08 | 1 |